GlassScriptPhysician profile
David J Schram
NPI 1689783763
$5,426.59
in general payments reported to CMS, 2019-2025
37 companies · $606 in 2025
The $606 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $629 · 2020: $668 · 2021: $696 · 2022: $895 · 2023: $1,195 · 2024: $738 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,464 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,463.86 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $929.40 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $705.02 | 2019-2025 | Qulipta, Vraylar, Ubrelvy |
| Novo Nordisk INC | $634.22 | 2019-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $478.82 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Pfizer INC. | $458.56 | 2019-2025 | |
| Amgen INC. | $269.18 | 2019-2024 | Repatha, Otezla |
| Janssen Pharmaceuticals, INC | $240.88 | 2019-2022 | |
| Allergan, INC. | $205.18 | 2019-2021 | |
| Astellas Pharma US INC | $200.75 | 2023-2024 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $181.58 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $162.11 | 2019-2024 | Jardiance, Tradjenta, Synjardy |
| Exact Sciences Corporation | $108.67 | 2023-2024 | Cologuard Collection Kit |
| Organon LLC | $84.99 | 2022-2025 | Nexplanon |
| Sanofi Pasteur INC. | $75.88 | 2019-2025 | |
| Xeris Pharmaceuticals, INC. | $71.70 | 2022-2023 | Gvoke Hypopen |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Schram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.